Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence
- PMID: 30482935
- PMCID: PMC6380927
- DOI: 10.1038/s41370-018-0097-y
Exposure to per-fluoroalkyl and polyfluoroalkyl substances leads to immunotoxicity: epidemiological and toxicological evidence
Abstract
In this perspective, we evaluate key and emerging epidemiological and toxicological data concerning immunotoxicity of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) and seek to reconcile conflicting conclusions from two reviews published in 2016. We summarize ways that immunosuppression and immunoenhancement are defined and explain how specific outcomes are used to evaluate immunotoxicity in humans and experimental animals. We observe that different approaches to defining immunotoxicological outcomes, particularly those that do not produce clinical disease, may lead to different conclusions from epidemiological and toxicological studies. The fundamental point that we make is that aspects of epidemiological studies considered as limitations can be minimized when data from toxicological studies support epidemiological findings. Taken together, we find that results of epidemiological studies, supported by findings from toxicological studies, provide strong evidence that humans exposed to PFOA and PFOS are at risk for immunosuppression.
Keywords: Emerging contaminants; Perfluorinated chemicals; Population-based studies.
Conflict of interest statement
Conflict of Interest
Dr. DeWitt reports that she was a protocol reviewer and a draft report reviewer for the NTP Monograph on Immunotoxicity Associated with Exposure to Perfluorooctanoic Acid or Perfluorooctane Sulfonate.
Figures
References
-
- Science Advisory Board (SAB). SAB Review of EPA’s Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and Its Salts. 2006.
-
- Yang Q, Xie Y, Eriksson AM, Nelson BD, DePierre JW. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem Pharmacol. 2001;62(8):1133–40. - PubMed
-
- Yang Q, Abedi-Valugerdi M, Xie Y, Zhao X-YY, Möller G, Dean Nelson B, et al. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol. 2002;2(2–3):389–97. - PubMed
-
- Organisation for Economic Cooperation and Development (OECD). Toward a New Comprehensive Global Database of Per- and Polyfluoroalkyl Substances (PFASs): Summary Report on Updating the OECD 2007 List of Per- and Polyfluoroalkyl Substances (PFASs). 2018. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
